Home > Products > Biosimilars

BioSIM anti-Human IL-33 Antibody (Etokimab Biosimilar), Research Grade

Catalog: SIM0308
Cost advantage to: SIM0053
Isotype: IgG1-kappa
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic biosimilar antibody shares variable regions with Etokimab (therapeutic humanized IgG1 mAb targeting human/cynomolgus monkey IL-33), ideal for research. IL-33 (IL-1 family cytokine from epithelial/endothelial/stromal cells) aids tissue homeostasis, immunity, inflammation and cancer. Etokimab inhibits IL-33/IL-12-induced IFN-γ in vitro and neutralizes IL-33 in diseases like AD, eosinophilic asthma.
 

Specifications

Product Name BioSIM anti-Human IL-33 Antibody (Etokimab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG1-kappa
Target IL-33
Other Names ANB020, CAS: 2022981-44-6, IL33
CAS 2022981-44-6
Reactivity Human
Host Species Humanized
Background This non-therapeutic biosimilar antibody shares variable regions with Etokimab (therapeutic humanized IgG1 mAb targeting human/cynomolgus monkey IL-33), ideal for research. IL-33 (IL-1 family cytokine from epithelial/endothelial/stromal cells) aids tissue homeostasis, immunity, inflammation and cancer. Etokimab inhibits IL-33/IL-12-induced IFN-γ in vitro and neutralizes IL-33 in diseases like AD, eosinophilic asthma.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products